Report Cover

Global Microbiomes Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The Microbiomes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microbiomes size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Microbiomes market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Microbiomes market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Gastrointestinal Microbiome
    Genitourinary Microbiome
    Skin Microbiome
    Respiratory Microbiome
    Other

Market segment by Application, can be divided into
    Testing
    Treatment
    Diagnosis
    Technology Platform
    Probiotics
    Other

Market segment by players, this report covers
    4D Pharma
    Enterome BioScience
    Evelo Biosciences
    Ferring
    Osel
    Second Genome
    Seres Therapeutics
    Synlogic
    Synthetic Biologics and Vedanta Biosciences
    Vedanta
    Rebiotix
    ActoGeniX
    Enterologics
    Metabogen
    Metabiomics
    Ritter Pharmaceuticals
    AvidBiotics
    Symberix
    Miomics
    Symbiotix Biotherapies
    MicroBiome Therapeutics LLC
    SciBac Inc

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of Microbiomes
    1.2 Classification of Microbiomes by Type
        1.2.1 Overview: Global Microbiomes Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Microbiomes Revenue Market Share by Type in 2020
        1.2.3 Gastrointestinal Microbiome
        1.2.4 Genitourinary Microbiome
        1.2.5 Skin Microbiome
        1.2.6 Respiratory Microbiome
        1.2.7 Other
    1.3 Global Microbiomes Market by Application
        1.3.1 Overview: Global Microbiomes Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Testing
        1.3.3 Treatment
        1.3.4 Diagnosis
        1.3.5 Technology Platform
        1.3.6 Probiotics
        1.3.7 Other
    1.4 Global Microbiomes Market Size & Forecast
    1.5 Global Microbiomes Market Size and Forecast by Region
        1.5.1 Global Microbiomes Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Microbiomes Market Size by Region, (2016-2021)
        1.5.3 North America Microbiomes Market Size and Prospect (2016-2026)
        1.5.4 Europe Microbiomes Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Microbiomes Market Size and Prospect (2016-2026)
        1.5.6 South America Microbiomes Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Microbiomes Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Microbiomes Market Drivers
        1.6.2 Microbiomes Market Restraints
        1.6.3 Microbiomes Trends Analysis
2 Company Profiles
    2.1 4D Pharma
        2.1.1 4D Pharma Details
        2.1.2 4D Pharma Major Business
        2.1.3 4D Pharma Microbiomes Product and Solutions
        2.1.4 4D Pharma Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 4D Pharma Recent Developments and Future Plans
    2.2 Enterome BioScience
        2.2.1 Enterome BioScience Details
        2.2.2 Enterome BioScience Major Business
        2.2.3 Enterome BioScience Microbiomes Product and Solutions
        2.2.4 Enterome BioScience Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Enterome BioScience Recent Developments and Future Plans
    2.3 Evelo Biosciences
        2.3.1 Evelo Biosciences Details
        2.3.2 Evelo Biosciences Major Business
        2.3.3 Evelo Biosciences Microbiomes Product and Solutions
        2.3.4 Evelo Biosciences Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Evelo Biosciences Recent Developments and Future Plans
    2.4 Ferring
        2.4.1 Ferring Details
        2.4.2 Ferring Major Business
        2.4.3 Ferring Microbiomes Product and Solutions
        2.4.4 Ferring Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Ferring Recent Developments and Future Plans
    2.5 Osel
        2.5.1 Osel Details
        2.5.2 Osel Major Business
        2.5.3 Osel Microbiomes Product and Solutions
        2.5.4 Osel Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Osel Recent Developments and Future Plans
    2.6 Second Genome
        2.6.1 Second Genome Details
        2.6.2 Second Genome Major Business
        2.6.3 Second Genome Microbiomes Product and Solutions
        2.6.4 Second Genome Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Second Genome Recent Developments and Future Plans
    2.7 Seres Therapeutics
        2.7.1 Seres Therapeutics Details
        2.7.2 Seres Therapeutics Major Business
        2.7.3 Seres Therapeutics Microbiomes Product and Solutions
        2.7.4 Seres Therapeutics Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Seres Therapeutics Recent Developments and Future Plans
    2.8 Synlogic
        2.8.1 Synlogic Details
        2.8.2 Synlogic Major Business
        2.8.3 Synlogic Microbiomes Product and Solutions
        2.8.4 Synlogic Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Synlogic Recent Developments and Future Plans
    2.9 Synthetic Biologics and Vedanta Biosciences
        2.9.1 Synthetic Biologics and Vedanta Biosciences Details
        2.9.2 Synthetic Biologics and Vedanta Biosciences Major Business
        2.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Product and Solutions
        2.9.4 Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Synthetic Biologics and Vedanta Biosciences Recent Developments and Future Plans
    2.10 Vedanta 
        2.10.1 Vedanta Details
        2.10.2 Vedanta Major Business
        2.10.3 Vedanta Microbiomes Product and Solutions
        2.10.4 Vedanta Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Vedanta Recent Developments and Future Plans
    2.11 Rebiotix
        2.11.1 Rebiotix Details
        2.11.2 Rebiotix Major Business
        2.11.3 Rebiotix Microbiomes Product and Solutions
        2.11.4 Rebiotix Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Rebiotix Recent Developments and Future Plans
    2.12 ActoGeniX
        2.12.1 ActoGeniX Details
        2.12.2 ActoGeniX Major Business
        2.12.3 ActoGeniX Microbiomes Product and Solutions
        2.12.4 ActoGeniX Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 ActoGeniX Recent Developments and Future Plans
    2.13 Enterologics
        2.13.1 Enterologics Details
        2.13.2 Enterologics Major Business
        2.13.3 Enterologics Microbiomes Product and Solutions
        2.13.4 Enterologics Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Enterologics Recent Developments and Future Plans
    2.14 Metabogen
        2.14.1 Metabogen Details
        2.14.2 Metabogen Major Business
        2.14.3 Metabogen Microbiomes Product and Solutions
        2.14.4 Metabogen Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Metabogen Recent Developments and Future Plans
    2.15 Metabiomics
        2.15.1 Metabiomics Details
        2.15.2 Metabiomics Major Business
        2.15.3 Metabiomics Microbiomes Product and Solutions
        2.15.4 Metabiomics Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Metabiomics Recent Developments and Future Plans
    2.16 Ritter Pharmaceuticals
        2.16.1 Ritter Pharmaceuticals Details
        2.16.2 Ritter Pharmaceuticals Major Business
        2.16.3 Ritter Pharmaceuticals Microbiomes Product and Solutions
        2.16.4 Ritter Pharmaceuticals Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Ritter Pharmaceuticals Recent Developments and Future Plans
    2.17 AvidBiotics
        2.17.1 AvidBiotics Details
        2.17.2 AvidBiotics Major Business
        2.17.3 AvidBiotics Microbiomes Product and Solutions
        2.17.4 AvidBiotics Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 AvidBiotics Recent Developments and Future Plans
    2.18 Symberix
        2.18.1 Symberix Details
        2.18.2 Symberix Major Business
        2.18.3 Symberix Microbiomes Product and Solutions
        2.18.4 Symberix Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 Symberix Recent Developments and Future Plans
    2.19 Miomics
        2.19.1 Miomics Details
        2.19.2 Miomics Major Business
        2.19.3 Miomics Microbiomes Product and Solutions
        2.19.4 Miomics Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.19.5 Miomics Recent Developments and Future Plans
    2.20 Symbiotix Biotherapies
        2.20.1 Symbiotix Biotherapies Details
        2.20.2 Symbiotix Biotherapies Major Business
        2.20.3 Symbiotix Biotherapies Microbiomes Product and Solutions
        2.20.4 Symbiotix Biotherapies Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.20.5 Symbiotix Biotherapies Recent Developments and Future Plans
    2.21 MicroBiome Therapeutics LLC
        2.21.1 MicroBiome Therapeutics LLC Details
        2.21.2 MicroBiome Therapeutics LLC Major Business
        2.21.3 MicroBiome Therapeutics LLC Microbiomes Product and Solutions
        2.21.4 MicroBiome Therapeutics LLC Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.21.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans
    2.22 SciBac Inc
        2.22.1 SciBac Inc Details
        2.22.2 SciBac Inc Major Business
        2.22.3 SciBac Inc Microbiomes Product and Solutions
        2.22.4 SciBac Inc Microbiomes Revenue, Gross Margin and Market Share (2019-2021)
        2.22.5 SciBac Inc Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Microbiomes Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Microbiomes Players Market Share
        3.2.2 Top 10 Microbiomes Players Market Share
        3.2.3 Market Competition Trend
    3.3 Microbiomes Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Microbiomes Revenue and Market Share by Type (2016-2021)
    4.2 Global Microbiomes Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Microbiomes Revenue Market Share by Application (2016-2021)
    5.2 Microbiomes Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Microbiomes Revenue by Type (2016-2026)
    6.2 North America Microbiomes Revenue by Application (2016-2026)
    6.3 North America Microbiomes Market Size by Country
        6.3.1 North America Microbiomes Revenue by Country (2016-2026)
        6.3.2 United States Microbiomes Market Size and Forecast (2016-2026)
        6.3.3 Canada Microbiomes Market Size and Forecast (2016-2026)
        6.3.4 Mexico Microbiomes Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Microbiomes Revenue by Type (2016-2026)
    7.2 Europe Microbiomes Revenue by Application (2016-2026)
    7.3 Europe Microbiomes Market Size by Country
        7.3.1 Europe Microbiomes Revenue by Country (2016-2026)
        7.3.2 Germany Microbiomes Market Size and Forecast (2016-2026)
        7.3.3 France Microbiomes Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Microbiomes Market Size and Forecast (2016-2026)
        7.3.5 Russia Microbiomes Market Size and Forecast (2016-2026)
        7.3.6 Italy Microbiomes Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Microbiomes Revenue by Type (2016-2026)
    8.2 Asia-Pacific Microbiomes Revenue by Application (2016-2026)
    8.3 Asia-Pacific Microbiomes Market Size by Region
        8.3.1 Asia-Pacific Microbiomes Revenue by Region (2016-2026)
        8.3.2 China Microbiomes Market Size and Forecast (2016-2026)
        8.3.3 Japan Microbiomes Market Size and Forecast (2016-2026)
        8.3.4 South Korea Microbiomes Market Size and Forecast (2016-2026)
        8.3.5 India Microbiomes Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Microbiomes Market Size and Forecast (2016-2026)
        8.3.7 Australia Microbiomes Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Microbiomes Revenue by Type (2016-2026)
    9.2 South America Microbiomes Revenue by Application (2016-2026)
    9.3 South America Microbiomes Market Size by Country
        9.3.1 South America Microbiomes Revenue by Country (2016-2026)
        9.3.2 Brazil Microbiomes Market Size and Forecast (2016-2026)
        9.3.3 Argentina Microbiomes Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Microbiomes Revenue by Type (2016-2026)
    10.2 Middle East & Africa Microbiomes Revenue by Application (2016-2026)
    10.3 Middle East & Africa Microbiomes Market Size by Country
        10.3.1 Middle East & Africa Microbiomes Revenue by Country (2016-2026)
        10.3.2 Turkey Microbiomes Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Microbiomes Market Size and Forecast (2016-2026)
        10.3.4 UAE Microbiomes Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Microbiomes Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Microbiomes Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Microbiomes Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Microbiomes Revenue (USD Million) by Region (2016-2021) Table 5. Global Microbiomes Revenue Market Share by Region (2021-2026) Table 6. 4D Pharma Corporate Information, Head Office, and Major Competitors Table 7. 4D Pharma Major Business Table 8. 4D Pharma Microbiomes Product and Solutions Table 9. 4D Pharma Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Enterome BioScience Corporate Information, Head Office, and Major Competitors Table 11. Enterome BioScience Major Business Table 12. Enterome BioScience Microbiomes Product and Solutions Table 13. Enterome BioScience Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Evelo Biosciences Corporate Information, Head Office, and Major Competitors Table 15. Evelo Biosciences Major Business Table 16. Evelo Biosciences Microbiomes Product and Solutions Table 17. Evelo Biosciences Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Ferring Corporate Information, Head Office, and Major Competitors Table 19. Ferring Major Business Table 20. Ferring Microbiomes Product and Solutions Table 21. Ferring Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Osel Corporate Information, Head Office, and Major Competitors Table 23. Osel Major Business Table 24. Osel Microbiomes Product and Solutions Table 25. Osel Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Second Genome Corporate Information, Head Office, and Major Competitors Table 27. Second Genome Major Business Table 28. Second Genome Microbiomes Product and Solutions Table 29. Second Genome Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Seres Therapeutics Corporate Information, Head Office, and Major Competitors Table 31. Seres Therapeutics Major Business Table 32. Seres Therapeutics Microbiomes Product and Solutions Table 33. Seres Therapeutics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Synlogic Corporate Information, Head Office, and Major Competitors Table 35. Synlogic Major Business Table 36. Synlogic Microbiomes Product and Solutions Table 37. Synlogic Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Synthetic Biologics and Vedanta Biosciences Corporate Information, Head Office, and Major Competitors Table 39. Synthetic Biologics and Vedanta Biosciences Major Business Table 40. Synthetic Biologics and Vedanta Biosciences Microbiomes Product and Solutions Table 41. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Vedanta Corporate Information, Head Office, and Major Competitors Table 43. Vedanta Major Business Table 44. Vedanta Microbiomes Product and Solutions Table 45. Vedanta Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Rebiotix Corporate Information, Head Office, and Major Competitors Table 47. Rebiotix Major Business Table 48. Rebiotix Microbiomes Product and Solutions Table 49. Rebiotix Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. ActoGeniX Corporate Information, Head Office, and Major Competitors Table 51. ActoGeniX Major Business Table 52. ActoGeniX Microbiomes Product and Solutions Table 53. ActoGeniX Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Enterologics Corporate Information, Head Office, and Major Competitors Table 55. Enterologics Major Business Table 56. Enterologics Microbiomes Product and Solutions Table 57. Enterologics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Metabogen Corporate Information, Head Office, and Major Competitors Table 59. Metabogen Major Business Table 60. Metabogen Microbiomes Product and Solutions Table 61. Metabogen Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Metabiomics Corporate Information, Head Office, and Major Competitors Table 63. Metabiomics Major Business Table 64. Metabiomics Microbiomes Product and Solutions Table 65. Metabiomics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Ritter Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 67. Ritter Pharmaceuticals Major Business Table 68. Ritter Pharmaceuticals Microbiomes Product and Solutions Table 69. Ritter Pharmaceuticals Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. AvidBiotics Corporate Information, Head Office, and Major Competitors Table 71. AvidBiotics Major Business Table 72. AvidBiotics Microbiomes Product and Solutions Table 73. AvidBiotics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. Symberix Corporate Information, Head Office, and Major Competitors Table 75. Symberix Major Business Table 76. Symberix Microbiomes Product and Solutions Table 77. Symberix Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 78. Miomics Corporate Information, Head Office, and Major Competitors Table 79. Miomics Major Business Table 80. Miomics Microbiomes Product and Solutions Table 81. Miomics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 82. Symbiotix Biotherapies Corporate Information, Head Office, and Major Competitors Table 83. Symbiotix Biotherapies Major Business Table 84. Symbiotix Biotherapies Microbiomes Product and Solutions Table 85. Symbiotix Biotherapies Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 86. MicroBiome Therapeutics LLC Corporate Information, Head Office, and Major Competitors Table 87. MicroBiome Therapeutics LLC Major Business Table 88. MicroBiome Therapeutics LLC Microbiomes Product and Solutions Table 89. MicroBiome Therapeutics LLC Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 90. SciBac Inc Corporate Information, Head Office, and Major Competitors Table 91. SciBac Inc Major Business Table 92. SciBac Inc Microbiomes Product and Solutions Table 93. SciBac Inc Microbiomes Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 94. Global Microbiomes Revenue (USD Million) by Players (2019-2021) Table 95. Global Microbiomes Revenue Share by Players (2019-2021) Table 96. Breakdown of Microbiomes by Company Type (Tier 1, Tier 2 and Tier 3) Table 97. Microbiomes Players Head Office, Products and Services Provided Table 98. Microbiomes Mergers & Acquisitions in the Past Five Years Table 99. Microbiomes New Entrants and Expansion Plans Table 100. Global Microbiomes Revenue (USD Million) by Type (2016-2021) Table 101. Global Microbiomes Revenue Share by Type (2016-2021) Table 102. Global Microbiomes Revenue Forecast by Type (2021-2026) Table 103. Global Microbiomes Revenue by Application (2016-2021) Table 104. Global Microbiomes Revenue Forecast by Application (2021-2026) Table 105. North America Microbiomes Revenue by Type (2016-2021) & (USD Million) Table 106. North America Microbiomes Revenue by Type (2021-2026) & (USD Million) Table 107. North America Microbiomes Revenue by Application (2016-2021) & (USD Million) Table 108. North America Microbiomes Revenue by Application (2021-2026) & (USD Million) Table 109. North America Microbiomes Revenue by Country (2016-2021) & (USD Million) Table 110. North America Microbiomes Revenue by Country (2021-2026) & (USD Million) Table 111. Europe Microbiomes Revenue by Type (2016-2021) & (USD Million) Table 112. Europe Microbiomes Revenue by Type (2021-2026) & (USD Million) Table 113. Europe Microbiomes Revenue by Application (2016-2021) & (USD Million) Table 114. Europe Microbiomes Revenue by Application (2021-2026) & (USD Million) Table 115. Europe Microbiomes Revenue by Country (2016-2021) & (USD Million) Table 116. Europe Microbiomes Revenue by Country (2021-2026) & (USD Million) Table 117. Asia-Pacific Microbiomes Revenue by Type (2016-2021) & (USD Million) Table 118. Asia-Pacific Microbiomes Revenue by Type (2021-2026) & (USD Million) Table 119. Asia-Pacific Microbiomes Revenue by Application (2016-2021) & (USD Million) Table 120. Asia-Pacific Microbiomes Revenue by Application (2021-2026) & (USD Million) Table 121. Asia-Pacific Microbiomes Revenue by Region (2016-2021) & (USD Million) Table 122. Asia-Pacific Microbiomes Revenue by Region (2021-2026) & (USD Million) Table 123. South America Microbiomes Revenue by Type (2016-2021) & (USD Million) Table 124. South America Microbiomes Revenue by Type (2021-2026) & (USD Million) Table 125. South America Microbiomes Revenue by Application (2016-2021) & (USD Million) Table 126. South America Microbiomes Revenue by Application (2021-2026) & (USD Million) Table 127. South America Microbiomes Revenue by Country (2016-2021) & (USD Million) Table 128. South America Microbiomes Revenue by Country (2021-2026) & (USD Million) Table 129. Middle East & Africa Microbiomes Revenue by Type (2016-2021) & (USD Million) Table 130. Middle East & Africa Microbiomes Revenue by Type (2021-2026) & (USD Million) Table 131. Middle East & Africa Microbiomes Revenue by Application (2016-2021) & (USD Million) Table 132. Middle East & Africa Microbiomes Revenue by Application (2021-2026) & (USD Million) Table 133. Middle East & Africa Microbiomes Revenue by Country (2016-2021) & (USD Million) Table 134. Middle East & Africa Microbiomes Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Microbiomes Picture Figure 2. Global Microbiomes Revenue Market Share by Type in 2020 Figure 3. Gastrointestinal Microbiome Figure 4. Genitourinary Microbiome Figure 5. Skin Microbiome Figure 6. Respiratory Microbiome Figure 7. Other Figure 8. Microbiomes Revenue Market Share by Application in 2020 Figure 9. Testing Picture Figure 10. Treatment Picture Figure 11. Diagnosis Picture Figure 12. Technology Platform Picture Figure 13. Probiotics Picture Figure 14. Other Picture Figure 15. Global Microbiomes Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 16. Global Microbiomes Revenue and Forecast (2016-2026) & (USD Million) Figure 17. Global Microbiomes Revenue Market Share by Region (2016-2026) Figure 18. Global Microbiomes Revenue Market Share by Region in 2020 Figure 19. North America Microbiomes Revenue (USD Million) and Growth Rate (2016-2026) Figure 20. Europe Microbiomes Revenue (USD Million) and Growth Rate (2016-2026) Figure 21. Asia-Pacific Microbiomes Revenue (USD Million) and Growth Rate (2016-2026) Figure 22. South America Microbiomes Revenue (USD Million) and Growth Rate (2016-2026) Figure 23. Middle East and Africa Microbiomes Revenue (USD Million) and Growth Rate (2016-2026) Figure 24. Microbiomes Market Drivers Figure 25. Microbiomes Market Restraints Figure 26. Microbiomes Market Trends Figure 27. 4D Pharma Recent Developments and Future Plans Figure 28. Enterome BioScience Recent Developments and Future Plans Figure 29. Evelo Biosciences Recent Developments and Future Plans Figure 30. Ferring Recent Developments and Future Plans Figure 31. Osel Recent Developments and Future Plans Figure 32. Second Genome Recent Developments and Future Plans Figure 33. Seres Therapeutics Recent Developments and Future Plans Figure 34. Synlogic Recent Developments and Future Plans Figure 35. Synthetic Biologics and Vedanta Biosciences Recent Developments and Future Plans Figure 36. Vedanta Recent Developments and Future Plans Figure 37. Rebiotix Recent Developments and Future Plans Figure 38. ActoGeniX Recent Developments and Future Plans Figure 39. Enterologics Recent Developments and Future Plans Figure 40. Metabogen Recent Developments and Future Plans Figure 41. Metabiomics Recent Developments and Future Plans Figure 42. Ritter Pharmaceuticals Recent Developments and Future Plans Figure 43. AvidBiotics Recent Developments and Future Plans Figure 44. Symberix Recent Developments and Future Plans Figure 45. Miomics Recent Developments and Future Plans Figure 46. Symbiotix Biotherapies Recent Developments and Future Plans Figure 47. MicroBiome Therapeutics LLC Recent Developments and Future Plans Figure 48. SciBac Inc Recent Developments and Future Plans Figure 49. Global Microbiomes Revenue Share by Players in 2020 Figure 50. Microbiomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 51. Global Top 3 Players Microbiomes Revenue Market Share in 2020 Figure 52. Global Top 10 Players Microbiomes Revenue Market Share in 2020 Figure 53. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 54. Global Microbiomes Revenue Share by Type in 2020 Figure 55. Global Microbiomes Market Share Forecast by Type (2021-2026) Figure 56. Global Microbiomes Revenue Share by Application in 2020 Figure 57. Global Microbiomes Market Share Forecast by Application (2021-2026) Figure 58. North America Microbiomes Sales Market Share by Type (2016-2026) Figure 59. North America Microbiomes Sales Market Share by Application (2016-2026) Figure 60. North America Microbiomes Revenue Market Share by Country (2016-2026) Figure 61. United States Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. Canada Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. Mexico Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. Europe Microbiomes Sales Market Share by Type (2016-2026) Figure 65. Europe Microbiomes Sales Market Share by Application (2016-2026) Figure 66. Europe Microbiomes Revenue Market Share by Country (2016-2026) Figure 67. Germany Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 68. France Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. United Kingdom Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. Russia Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Italy Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Asia-Pacific Microbiomes Sales Market Share by Type (2016-2026) Figure 73. Asia-Pacific Microbiomes Sales Market Share by Application (2016-2026) Figure 74. Asia-Pacific Microbiomes Revenue Market Share by Region (2016-2026) Figure 75. China Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. Japan Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 77. South Korea Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. India Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. Southeast Asia Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. Australia Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 81. South America Microbiomes Sales Market Share by Type (2016-2026) Figure 82. South America Microbiomes Sales Market Share by Application (2016-2026) Figure 83. South America Microbiomes Revenue Market Share by Country (2016-2026) Figure 84. Brazil Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 85. Argentina Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 86. Middle East and Africa Microbiomes Sales Market Share by Type (2016-2026) Figure 87. Middle East and Africa Microbiomes Sales Market Share by Application (2016-2026) Figure 88. Middle East and Africa Microbiomes Revenue Market Share by Country (2016-2026) Figure 89. Turkey Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 90. Saudi Arabia Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 91. UAE Microbiomes Revenue and Growth Rate (2016-2026) & (USD Million) Figure 92. Methodology Figure 93. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us